戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ere safely administered to the patient via a peripheral vein.
2 rtal vein, hepatic vein, and an arterialized peripheral vein.
3 usion was switched from the portal vein to a peripheral vein.
4 93 and 1998 who received Atgam induction via peripheral vein.
5  administered into the portal vein or into a peripheral vein.
6 d drawn from the internal jugular vein and a peripheral vein.
7 asured vitamin C and cortisol in adrenal and peripheral veins.
8 njected with repeated doses of ADHLSCs via a peripheral vein (35 million In-oxine-labeled cells, foll
9  with preexisting immunity to AAV8 following peripheral vein administration of 1x10(12) vg/kg AAV5-ps
10                        Within 48 hours after peripheral vein administration of the vector to FVIII-de
11 matic VTE (two involving the deep veins, one peripheral vein and one pulmonary embolism).
12 l procedures included US localization of the peripheral vein and postprocedural chest radiograph to a
13 of exercise, somatostatin was infused into a peripheral vein, and insulin and glucagon were infused i
14  portal vein (4 mg x kg(-1) x min(-1)) and a peripheral vein, as needed, to maintain arterial plasma
15 energic agonist dobutamine was infused via a peripheral vein before and during concurrent intracorona
16 ial blood sampling of the coronary sinus and peripheral vein before, during, and after infusion allow
17 7 proteins that significantly changed in the peripheral vein blood after PMI in a derivation cohort (
18 ive simultaneous central venous catheter and peripheral vein blood cultures were included.
19 erventions, such as coronary angioplasty and peripheral vein grafting.
20 X (FIX) transgene (scAAV2/8-LP1-hFIXco) in a peripheral vein in six patients with severe hemophilia B
21                                              Peripheral vein infusion is safe, convenient, and econom
22                                              Peripheral vein infusion of 1x10(12) vg/kg scAAV-LP1-hFI
23    Equine ATG can be safely administered via peripheral vein infusion.
24                                              Peripheral-vein infusion of scAAV2/8-LP1-hFIXco resulted
25                  In adult macaques, a single peripheral vein injection of 2 x 10(11) vg/kg of the hFV
26 an ultrasound contrast agent injected into a peripheral vein is accelerated in patients with cirrhosi
27 ence of thrombotic events in visceral and/or peripheral veins or arteries (HR 7.66, 95% CI 2.13-27.51
28                      Pulmonary vein (PV) and peripheral vein (Pe) blood specimens from patients with
29                             The jugular vein/peripheral vein ratio was 1.4 in patients with MS vs. 1.
30 drawn through either the central catheter or peripheral vein shows excellent negative predictive valu
31 e safely administered equine ATG (Atgam) via peripheral veins since 1978.
32 res from the central venous catheter and the peripheral vein to become positive, as well as other rel
33 a fourfold basal rate (PoI, n = 6), or via a peripheral vein to create a selective increase in the ar
34                Glucose was infused through a peripheral vein to create hyperglycemia (12.5 mmol/l pla
35 omol/L at 1-4 min, whereas the corresponding peripheral vein vitamin C concentrations were 35 +/- 15
36 e stimulation increases adrenal vein but not peripheral vein vitamin C concentrations.
37 normal saline during 20 to 30 minutes into a peripheral vein with a high-pressure bag.
38 tures should be performed, preferably from a peripheral vein, without interval between samples to avo

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。